Application 021268

Type
NDA
Sponsor
ABBVIE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TEVETEN HCTEPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDETABLET;ORAL600MG;12.5MGNoNo
002TEVETEN HCTEPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDETABLET;ORAL600MG;25MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021268-001TEVETEN HCTEPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE600MG;12.5MGTABLET / ORAL2001-11-01
N021268-002TEVETEN HCTEPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE600MG;25MGTABLET / ORAL2001-11-01

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 88 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-10-28 04:53 UTC2022-10N021268-001TEVETEN HCT600MG;12.5MGTABLET / ORAL2001-11-01f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N021268-002TEVETEN HCT600MG;25MGTABLET / ORAL2001-11-01f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N021268-001TEVETEN HCT600MG;12.5MGTABLET / ORAL2001-11-01e64feba35796…
2022-09-29 23:25 UTC2022-09N021268-002TEVETEN HCT600MG;25MGTABLET / ORAL2001-11-01e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N021268-001TEVETEN HCT600MG;12.5MGTABLET / ORAL2001-11-01cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N021268-002TEVETEN HCT600MG;25MGTABLET / ORAL2001-11-01cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N021268-001TEVETEN HCT600MG;12.5MGTABLET / ORAL2001-11-01a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N021268-002TEVETEN HCT600MG;25MGTABLET / ORAL2001-11-01a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
27300SUPPL2014-07-24
14815SUPPL2014-07-24
36527SUPPL2012-09-14
27299SUPPL2012-09-14
36526SUPPL2012-01-23
27298SUPPL2012-01-23
23640ORIG2011-12-22
4850SUPPL2011-05-25
4849SUPPL2011-05-25
14814SUPPL2011-05-23
14813SUPPL2011-05-23
4848SUPPL2005-07-15
27296SUPPL2003-10-17
27297SUPPL2003-07-10
42066ORIG2002-03-05
36525ORIG2001-11-01
27295ORIG2001-11-01